CF
PRME icon

Corebridge Financial’s Prime Medicine PRME Stock Holding History

Corebridge Financial’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,785
Closed -$55.3K – 2093
2025
Q1 		$55.3K Sell
27,785
-412
-1% -$1.05K ﹤0.01% 2701
2024
Q4 		$82.3K Sell
28,197
-2,128
-7% -$7.47K ﹤0.01% 2637
2024
Q3 		$117K Sell
30,325
-187
-0.6% -$866 ﹤0.01% 2531
2024
Q2 		$157K Buy
+30,512
New +$185K ﹤0.01% 2342

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Corebridge Financial's PRME Position: Q2 2025 in Review

Corebridge Financial sold out of Prime Medicine (PRME) in Q2 2025, closing a stake of 27,785 shares — an estimated $55.3K sold.

Corebridge Financial first reported a position in PRME in Q2 2024 and held it in 4 quarters. The position peaked at $157K in Q2 2024. 121 funds tracked by Wall St. Rank hold PRME as of Q2 2025.

  • Corebridge Financial reported no remaining Prime Medicine position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 27,785 Prime Medicine shares in Q2 2025, an estimated $55.3K.
  • Corebridge Financial first reported a position in Prime Medicine in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Prime Medicine position peaked at $157K in Q2 2024.
  • 121 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.